Emotional reactivity, functioning, and C-reactive protein alterations in remitted bipolar patients: Clinical relevance of a dimensional approach

Australian and New Zealand Journal of Psychiatry

Volumn 51, Issue 8, 2017, Pages 788-798

  Dargél, Aroldo A ^a,b   Godin, Ophelia ^c,d   Etain, Bruno ^d,e,f,g   Hirakata, Vânia ^h   Azorin, Jean Michel ^e,i   M'Bailara, Katia ^e,i,j   Bellivier, Frank ^e,k   Bougerol, Thierry ^e,l,m,n   Kahn, Jean Pierre ^e,o   Passerieux, Christine ^e,p,q   Aubin, Valerie ^e,r   Courtet, Philippe ^e,s,t,u   Leboyer, Marion ^d,e,f,g   Henry, Chantal ^a,e,f,g  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c INSERM   (France)

^d FONDATION FONDAMENTAL   (France)

^e INSERM U955   (France)

^f UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^g HENRI MONDOR HOSPITAL   (France)

^h HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

ⁱ CENTRE HOSPITALIER CHARLES PERRENS   (France)

^j UNIVERSITÉ DE BORDEAUX   (France)

^k SAINT LOUIS HOSPITAL   (France)

^l UNIV GRENOBLE ALPES   (France)

^m GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁿ GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^o CHU NANCY BRABOIS   (France)

^p CENTRE HOSPITALIER DE VERSAILLES   (France)

^q LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^r CENTRE HOSPITALIER PRINCESSE GRACE   (Monaco)

^s MONTPELLIER UNIVERSITY HOSPITAL   (France)

^t INSERM U1061   (France)

^u HÔPITAL SAINTE MARGUERITE   (France)

more..

Author keywords

Bipolar disorder; C reactive protein; dimensional approach; emotional reactivity; psychosocial functioning

Indexed keywords

C REACTIVE PROTEIN;

ADULT; BIPOLAR DISORDER; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; EMOTION; EMOTIONAL DISORDER; EMOTIONAL REACTIVITY; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; BLOOD; DISEASE EXACERBATION; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AFFECTIVE SYMPTOMS; BIPOLAR DISORDER; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 85020912350     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867417691850     Document Type: Review

References (52)

1. Appleton AA, Buka SL, Loucks EB, et al. (2013) Divergent associations of adaptive and maladaptive emotion regulation strategies with inflammation. Health Psychology 32: 748-756.
2. Atzeni T, Henry C, Minois I, et al. (2013) From inhibition to activation, from emotional hyporeactivity to emotional hyperreactivity: Two pathways to discriminate mood in bipolar disorders. Psychiatry Research 209: 50-54.
3. Ayub Dargél A, Masson M, Henry C, (2016) The RANZCP guidelines: Managing mood disorders in the real world. Australian and New Zealand Journal of Psychiatry 50: 1198-1199.
4. Berk M, Kapczinski F, Andreazza AC, et al. (2011) Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience & Biobehavioral Reviews 35: 804-817.
5. Bonnín CM, Sánchez-Moreno J, Martínez-Arán A, et al. (2012) Subthreshold symptoms in bipolar disorder: Impact on neurocognition, quality of life and disability. Journal of Affective Disorders 136: 650-659.
6. Bonnin CM, Torrent C, Arango C, et al. (2016) Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. The British Journal of Psychiatry 208: 87-93.
7. Bonsall MB, Wallace-Hadrill SMA, Geddes JR, et al. (2012) Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder. Proceedings of the Royal Society B: Biological Sciences 279: 916-924.
8. Broome MR, He Z, Iftikhar M, et al. (2015 a) Neurobiological and behavioural studies of affective instability in clinical populations: A systematic review. Neuroscience & Biobehavioral Reviews 51: 243-254.
9. Broome MR, Saunders KEA, Harrison PJ, et al. (2015 b) Mood instability: Significance, definition and measurement. The British Journal of Psychiatry 207: 283-285.
10. Danese A, Moffitt TE, Pariante CM, et al. (2008) Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Archives of General Psychiatry 65: 409-415.
11. Dargél AA, Godin O, Kapczinski F, et al. (2015) C-reactive protein alterations in bipolar disorder: A meta-analysis. The Journal of Clinical Psychiatry 76: 142-150.
12. Dickerson F, Stallings C, Origoni A, et al. (2013) Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. Journal of Affective Disorders 150: 456-459.
13. Dittmann S, Seemüller F, Grunze HC, et al. (2008) The impact of homocysteine levels on cognition in euthymic bipolar patients: A cross-sectional study. The Journal of Clinical Psychiatry 69: 899-906.
14. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 375: 132-140.
15. First MB, Spitzer RL, Gibbon M, et al. (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York: Biometrics Research, New York State Psychiatric Institute.
16. Gabay C, Kushner I, (1999) Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine 340: 448-454.
17. Glenn T, Monteith S, (2014) New measures of mental state and behavior based on data collected from sensors, smartphones, and the internet. Current Psychiatry Reports 16: 523. Available at: http://link.springer.com/10.1007/s11920-014-0523-3 (. accessed 9 September 2015).
18. Goldstein BI, Kemp DE, Soczynska JK, et al. (2009) Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: A systematic review of the literature. The Journal of Clinical Psychiatry 70: 1078-1090.
19. Grande I, Berk M, Birmaher B, et al. (2016) Bipolar disorder. Lancet 387: 1561-1572.
20. Gross JJ, (1998) The emerging field of emotion regulation: An integrative review. Review of General Psychology 2: 271-299.
21. Gruber J, Harvey AG, Purcell A, (2011) What goes up can come down? A preliminary investigation of emotion reactivity and emotion recovery in bipolar disorder. Journal of Affective Disorders 133: 457-466.
22. Haarman BBC, Riemersma-Van der Lek RF, Burger H, et al. (2014) Relationship between clinical features and inflammation-related monocyte gene expression in bipolar disorder: Towards a better understanding of psychoimmunological interactions. Bipolar Disorders 16: 137-150.
23. Henry C, Etain B, (2010) New ways to classify bipolar disorders: Going from categorical groups to symptom clusters or dimensions. Current Psychiatry Reports 12: 505-511.
24. Henry C, Etain B, Godin O, et al. (2015) Bipolar patients referred to specialized services of care: Not resistant but impaired by sub-syndromal symptoms. Results from the FACE-BD cohort. Australian and New Zealand Journal of Psychiatry 49: 898-905.
25. Henry C, Etain B, Mathieu F, et al. (2011) A French network of bipolar expert centres: A model to close the gap between evidence-based medicine and routine practice. Journal of Affective Disorders 131: 358-363.
26. Henry C, M'Bailara K, Lépine J-P, et al. (2010) Defining bipolar mood states with quantitative measurement of inhibition/activation and emotional reactivity. Journal of Affective Disorders 127: 300-304.
27. Henry C, M'Bailara K, Mathieu F, et al. (2008) Construction and validation of a dimensional scale exploring mood disorders: MAThyS (Multidimensional Assessment of Thymic States). BMC Psychiatry 8: 82.
28. Henry C, M'Bailara K, Poinsot R, et al. (2007) Evidence for two types of bipolar depression using a dimensional approach. Psychotherapy and Psychosomatics 76: 325-331.
29. Hsuchou H, Kastin AJ, Mishra PK, et al. (2012) C-reactive protein increases BBB permeability: Implications for obesity and neuroinflammation. Cellular Physiology and Biochemistry 30: 1109-1119.
30. Insel T, Cuthbert B, Garvey M, et al. (2010) Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. The American Journal of Psychiatry 167: 748-751.
31. Kazis LE, Anderson JJ, Meenan RF, (1989) Effect sizes for interpreting changes in health status. Medical Care 27 (3 Suppl): 178-189.
32. McEwen BS, (2003) Mood disorders and allostatic load. Biological Psychiatry 54: 200-207.
33. Malhi GS, (2015) Antidepressants in bipolar depression: Yes, no, maybe? Evidence-Based Mental Health 18: 100-102.
34. Malhi GS, Porter R, (2016) Mood disorders are categorically dimensional! Australian and New Zealand Journal of Psychiatry 50: 1038-1039.
35. Malhi GS, Bassett D, Boyce P, et al. (2015) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian and New Zealand Journal of Psychiatry 49: 1087-1206.
36. Marwaha S, He Z, Broome M, et al. (2014) How is affective instability defined and measured? A systematic review. Psychological Medicine 44: 1793-1808.
37. Miller GE, Cohen S, Ritchey AK, (2002) Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association 21: 531-541.
38. Modabbernia A, Taslimi S, Brietzke E, et al. (2013) Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies. Biological Psychiatry 74: 15-25.
39. O'Connor M-F, Bower JE, Cho HJ, et al. (2009) To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers. Brain, Behavior, and Immunity 23: 887-897.
40. O'Neil A, Jacka FN, Quirk SE, et al. (2015) A shared framework for the common mental disorders and Non-Communicable Disease: Key considerations for disease prevention and control. BMC Psychiatry 15: 15.
41. Padmos RC, Hillegers MHJ, Knijff EM, et al. (2008) A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Archives of General Psychiatry 65: 395-407.
42. Pepys MB, Hirschfield GM, (2003) C-reactive protein: A critical update. Journal of Clinical Investigation 111: 1805-1812.
43. Phillips ML, Kupfer DJ, (2013) Bipolar disorder diagnosis: Challenges and future directions. Lancet 381: 1663-1671.
44. Phillips ML, Ladouceur CD, Drevets WC, (2008) A neural model of voluntary and automatic emotion regulation: Implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Molecular Psychiatry 13: 829-857.
45. Rosa AR, Franco C, Martínez-Aran A, et al. (2008) Functional impairment in patients with remitted bipolar disorder. Psychotherapy and Psychosomatics 77: 390-392.
46. Rosa AR, Magalhaes PV, Czepielewski L, et al. (2014) Clinical staging in bipolar disorder: Focus on cognition and functioning. The Journal of Clinical Psychiatry 75: e450-e456.
47. Strejilevich SA, Martino DJ, Murru A, et al. (2013) Mood instability and functional recovery in bipolar disorders. Acta Psychiatrica Scandinavica 128: 194-202.
48. Szabó C, Kelemen O, Kéri S, (2014) Low-grade inflammation disrupts structural plasticity in the human brain. Neuroscience 275: 81-88.
49. Tohen M, Frank E, Bowden CL, et al. (2009) The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disorders 11: 453-473.
50. Van Rheenen TE, Meyer D, Rossell SL, (2014) Pathways between neurocognition, social cognition and emotion regulation in bipolar disorder. Acta Psychiatrica Scandinavica 130: 397-405.
51. Vieta E, Popovic D, Rosa AR, et al. (2013) The clinical implications of cognitive impairment and allostatic load in bipolar disorder. European Psychiatry 28: 21-29.
52. Wium-Andersen MK, Orsted DD, Nordestgaard BG, (2016) Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population. The British Journal of Psychiatry 208: 138-145.